Corcept Therapeutics (CORT) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $81.93 --0%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
UVV, SII, SCKT, More
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
UVV, SII, SCKT, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $135.4 million versus the consensus estimate of $130.31 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises Keurig Dr Pepper price target to $40
- Latham Group, Inc. (SWIM) Misses Q3 EPS by 5c ; Offers Guidance
- Corcept Therapeutics (CORT) Tops Q3 EPS by 22c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
